Posterior reversible encephalopathy syndrome

Clinical Advances in Hematology and Oncology

Volumn 10, Issue 9, 2012, Pages 614-615

  Marrone, Luiz Carlos Porcello ^a   Marrone, Bianca Fontana ^a   Gadonski, Giovani ^a   Marrone, Antônio Carlos Huf ^a   da Costa, Jaderson Costa ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE;

AUTOREGULATION; BLOOD PRESSURE; BLOOD VESSEL INJURY; BLURRED VISION; BRAIN EDEMA; BREAST CANCER; CHEMOTHERAPY; ECLAMPSIA; HUMAN; HYPERTENSION; KIDNEY DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PANCREAS ADENOCARCINOMA; PARIETAL LOBE; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; REVIEW; TONIC CLONIC SEIZURE; TRANSPLANTATION;

HUMANS; MAGNETIC RESONANCE IMAGING; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME;

EID: 84867803686     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494-500.
2. Casey SO, Sampaio RC, Michel E, et al. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol. 2000;21:1199-1206.
3. Schwartz RB. Hyperperfusion encephalopathies: hypertensive encephalopathy and related conditions. Neurologist. 2002;8:22-34.
4. Bartynski WS, Boardman JF. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2008;29:447-455.
5. Auer LM. The pathogenisis of hypertensive encephalopathy: experimental data and their clinical relevance with special reference to neurosurgical patients. Acta Neurochir Suppl (Wien). 1978;27:1-111.
6. Feske SK. Posterior reversible encephalopathy syndrome: a review. Semin Neurol. 2011;31:202-215.
7. Lamy C, Oppenheim C, Méder JF, Mas JL. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging. 2004;14:89-96.
8. Marrone LCP, Marrone BF, Raya JP, et al. Gemcitabine monotherapy associated with posterior reversible encephalopathy syndrome. Case Rep Oncol. 2011;4:82-87.
9. Liman TG, Bohner G, Heuschmann PU, Endres M, Siebert E. The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study. J Neurol. 2011 Jun 30. [Epub ahead of print]
10. Schwartz RB, Feske SK, Polak JF, et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology. 2000;217:371-376.
11. Colosimo C Jr, Fileni A, Moschini M, et al. CT findings in eclampsia. Neuroradiology. 1985;27:313-317.
12. Lewis LK, Hinshaw DB Jr, Will AD, et al. CT and angiographic correlation of severe neurological disease in toxemia of pregnancy. Neuroradiology. 1988;30:59-64.
13. Bartynski WS, Tan HP, Boardman JF, et al. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol. 2008;29:924-930.
14. Gokce M, Dogan E, Nacitarhan S, Demirpolat G. Posterior reversible encephalopathy syndrome caused by hypertensive encephalopathy and acute uremia. Neurocrit Care. 2006;4:133-136.
15. Quoc T, Jame A, Govardhanan N, Mike N, Lauren V. Gemcitabine associated with posterior reversible encephalopathy syndrome (PRES): a case report and review of the literature. Clin Adv Hematol Oncol. 2012;10:611-613.
16. Rajasekhar A, George TJ Jr. Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of literature. Oncologist. 2007;12:1332-1335.
17. Cooney MJ, Bradley WG, Symko SC, Patel ST, Groncy PK. Hypertensive encephalopathy: complication in children treated for myeloproliferative disorders- report of three cases. Radiology. 2000;214:711-716.
18. Morris EB, Laningham FH, Sandlund JT, Khan RB: Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer. 2007;48:152-159.